SG11202005138TA - Imidazopyridine derivatives and the use thereof as medicament - Google Patents

Imidazopyridine derivatives and the use thereof as medicament

Info

Publication number: SG11202005138TA
Authority: SG; Singapore
Prior art keywords: medicament; imidazopyridine derivatives; imidazopyridine; derivatives
Prior art date: 2017-12-08

Application number

SG11202005138TA

Inventor

Riccardo Giovannini

Angelo Ceci

Georg Dahmann

Cornelia Dorner-Ciossek

Lothar Kussmaul

Roland Pfau

Dieter Wiedenmayer

Original Assignee

Boehringer Ingelheim Int

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2017-12-08

Filing date

2018-12-06

Publication date

2020-06-29

2018-12-06 Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int

2020-06-29 Publication of SG11202005138TA publication Critical patent/SG11202005138TA/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Neurosurgery (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Pyrane Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Medicines Containing Plant Substances (AREA)
Plural Heterocyclic Compounds (AREA)
Pyrrole Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

SG11202005138TA 2017-12-08 2018-12-06 Imidazopyridine derivatives and the use thereof as medicament SG11202005138TA (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP17206152		2017-12-08
PCT/EP2018/083728 WO2019110703A1 (en)	2017-12-08	2018-12-06	Imidazopyridine derivatives and the use thereof as medicament

Publications (1)

Publication Number	Publication Date
SG11202005138TA true SG11202005138TA (en)	2020-06-29

Family

ID=60629568

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SG11202005138TA SG11202005138TA (en)	2017-12-08	2018-12-06	Imidazopyridine derivatives and the use thereof as medicament

Country Status (30)

Country	Link
US (1)	US10849907B2 (en)
EP (1)	EP3720855B1 (en)
JP (1)	JP6941235B2 (en)
CN (1)	CN111344291B (en)
AR (1)	AR113923A1 (en)
AU (1)	AU2018379438B2 (en)
BR (1)	BR112020008583A2 (en)
CA (1)	CA3083331A1 (en)
CL (1)	CL2020001402A1 (en)
CO (1)	CO2020006648A2 (en)
CY (1)	CY1124744T1 (en)
DK (1)	DK3720855T3 (en)
EA (1)	EA202091139A1 (en)
ES (1)	ES2897050T3 (en)
HR (1)	HRP20211726T1 (en)
HU (1)	HUE056667T2 (en)
IL (1)	IL274868B2 (en)
LT (1)	LT3720855T (en)
MA (1)	MA51020B1 (en)
MX (1)	MX2020005869A (en)
PE (1)	PE20211454A1 (en)
PL (1)	PL3720855T3 (en)
PT (1)	PT3720855T (en)
RS (1)	RS62517B1 (en)
SA (1)	SA520412155B1 (en)
SG (1)	SG11202005138TA (en)
SI (1)	SI3720855T1 (en)
TW (1)	TWI809014B (en)
UA (1)	UA126247C2 (en)
WO (1)	WO2019110703A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US11376258B2 (en)	2019-06-04	2022-07-05	Boehringer Ingelheim International Gmbh	Purine derivatives and the use thereof as medicament
WO2020245137A1 (en) *	2019-06-04	2020-12-10	Boehringer Ingelheim International Gmbh	Imidazopyrazine derivatives and the use thereof as medicament

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6495561B2 (en) *	1999-10-29	2002-12-17	Merck & Co., Inc.	2-cyclohexyl imidazopyridine NMDA/NR2B antagonists
KR100890676B1 (en)	2001-07-24	2009-03-26	리히데 게데온 베기에스제티 기아르 알티	New carboxylic acid amide compounds
WO2010088414A2 (en)	2009-01-28	2010-08-05	Emory University	Subunit selective nmda receptor potentiators for the treatment of neurological conditions
UA114529C2 (en)	2012-10-18	2017-06-26	Ф. Хоффманн-Ля Рош Аг	Ethynyl derivatives as modulators of mglur5 receptor activity
WO2015130905A1 (en)	2014-02-27	2015-09-03	Merck Patent Gmbh	Heterocyclic compounds as nav channel inhibitors and uses thereof
JP2017516836A (en) *	2014-06-04	2017-06-22	リューゲンホールディングス（ケイマン）リミテッド	Difluoroethylpyridine derivatives as NR2BNMDA receptor antagonists
WO2016029146A1 (en)	2014-08-22	2016-02-25	University Of Washington	Specific inhibitors of methionyl-trna synthetase
EP3194403B1 (en) *	2014-09-15	2019-02-06	Rugen Holdings (Cayman) Limited	Pyrrolopyrimidine derivatives as nr2b nmda receptor antagonists

2018
- 2018-12-06 SG SG11202005138TA patent/SG11202005138TA/en unknown
- 2018-12-06 MA MA51020A patent/MA51020B1/en unknown
- 2018-12-06 CA CA3083331A patent/CA3083331A1/en active Pending
- 2018-12-06 MX MX2020005869A patent/MX2020005869A/en unknown
- 2018-12-06 WO PCT/EP2018/083728 patent/WO2019110703A1/en active Application Filing
- 2018-12-06 PE PE2020000681A patent/PE20211454A1/en unknown
- 2018-12-06 LT LTEPPCT/EP2018/083728T patent/LT3720855T/en unknown
- 2018-12-06 EA EA202091139A patent/EA202091139A1/en unknown
- 2018-12-06 BR BR112020008583-9A patent/BR112020008583A2/en unknown
- 2018-12-06 PT PT188265102T patent/PT3720855T/en unknown
- 2018-12-06 RS RS20211347A patent/RS62517B1/en unknown
- 2018-12-06 UA UAA202003988A patent/UA126247C2/en unknown
- 2018-12-06 PL PL18826510T patent/PL3720855T3/en unknown
- 2018-12-06 DK DK18826510.2T patent/DK3720855T3/en active
- 2018-12-06 US US16/211,355 patent/US10849907B2/en active Active
- 2018-12-06 SI SI201830440T patent/SI3720855T1/en unknown
- 2018-12-06 AU AU2018379438A patent/AU2018379438B2/en active Active
- 2018-12-06 HR HRP20211726TT patent/HRP20211726T1/en unknown
- 2018-12-06 EP EP18826510.2A patent/EP3720855B1/en active Active
- 2018-12-06 JP JP2020530609A patent/JP6941235B2/en active Active
- 2018-12-06 ES ES18826510T patent/ES2897050T3/en active Active
- 2018-12-06 IL IL274868A patent/IL274868B2/en unknown
- 2018-12-06 CN CN201880072962.4A patent/CN111344291B/en active Active
- 2018-12-06 HU HUE18826510A patent/HUE056667T2/en unknown
- 2018-12-07 AR ARP180103599A patent/AR113923A1/en unknown
- 2018-12-07 TW TW107144026A patent/TWI809014B/en active
2020
- 2020-05-27 CL CL2020001402A patent/CL2020001402A1/en unknown
- 2020-05-29 CO CONC2020/0006648A patent/CO2020006648A2/en unknown
- 2020-06-08 SA SA520412155A patent/SA520412155B1/en unknown
2021
- 2021-11-16 CY CY20211100993T patent/CY1124744T1/en unknown

Also Published As

Publication number	Publication date
HUE056667T2 (en)	2022-02-28
US10849907B2 (en)	2020-12-01
CA3083331A1 (en)	2019-06-13
EP3720855B1 (en)	2021-08-25
EA202091139A1 (en)	2020-11-23
IL274868B1 (en)	2024-02-01
TW201936198A (en)	2019-09-16
WO2019110703A1 (en)	2019-06-13
CN111344291B (en)	2023-05-05
PL3720855T3 (en)	2022-01-24
SI3720855T1 (en)	2021-12-31
US20190175605A1 (en)	2019-06-13
JP2021505584A (en)	2021-02-18
RS62517B1 (en)	2021-11-30
CL2020001402A1 (en)	2020-09-21
HRP20211726T1 (en)	2022-02-18
MA51020A (en)	2021-05-26
KR20200097301A (en)	2020-08-18
CO2020006648A2 (en)	2020-06-09
EP3720855A1 (en)	2020-10-14
IL274868B2 (en)	2024-06-01
IL274868A (en)	2020-07-30
LT3720855T (en)	2021-11-10
MA51020B1 (en)	2021-10-29
CY1124744T1 (en)	2022-07-22
DK3720855T3 (en)	2021-11-08
AR113923A1 (en)	2020-07-01
MX2020005869A (en)	2020-09-09
SA520412155B1 (en)	2022-06-05
AU2018379438A1 (en)	2020-05-07
ES2897050T3 (en)	2022-02-28
PT3720855T (en)	2021-11-03
BR112020008583A2 (en)	2020-10-20
TWI809014B (en)	2023-07-21
AU2018379438B2 (en)	2022-08-18
CN111344291A (en)	2020-06-26
UA126247C2 (en)	2022-09-07
PE20211454A1 (en)	2021-08-05
JP6941235B2 (en)	2021-09-29

Publication	Publication Date	Title
IL246757A0 (en)	2016-08-31	Novel insulin derivatives and the medical uses hereof
IL257173A (en)	2018-06-28	Novel insulin derivatives and the medical uses hereof
GB201715194D0 (en)	2017-11-01	Compounds and their therapeutic use
PL3421038T3 (en)	2020-06-29	Naphthyridine compound, pharmaceutical composition and use thereof
IL282527A (en)	2021-06-30	Azaindazole-5 derivatives and their use
IL282526A (en)	2021-06-30	Azaindazole-5 derivatives and their use
EP3302530A4 (en)	2018-10-31	Cdh26 based therapeutic agents and their use
IL274868A (en)	2020-07-30	Imidazopyridine derivatives and the use thereof as medicament
IL282142A (en)	2021-05-31	4-pyrazin-2-ylmethyl-morpholine derivatives and the use thereof as medicament
ZA201607353B (en)	2018-05-30	Bicyclic derivatives and pharmaceutical composition including the same
ZA202000959B (en)	2021-08-25	Adamantylmethylamine derivative and use thereof as pharmaceutical
EP3227293A4 (en)	2018-09-12	6.7-cyclicmorphinan derivatives and use thereof
PL3250181T3 (en)	2020-11-16	Minoxidil-based pharmaceutical formulation for the topical use and kit thereof
EP3192513A4 (en)	2018-06-06	7-fluoro-8-chloro-5 -dibenzo[b,e][1,4]diazepine derivatives and use thereof
HK1251558A1 (en)	2019-02-01	Novel imide derivatives and use thereof as medicine
HRP20182167T1 (en)	2019-02-08	Benzylhydroxyde derivatives, preparation thereof and therapeutic use thereof
PT3606534T (en)	2021-07-16	Phospholipid derivatives and their use as medicaments